ROMANELLI, ROBERTO GIULIO
 Distribuzione geografica
Continente #
NA - Nord America 6.967
EU - Europa 4.532
AS - Asia 916
AF - Africa 31
Continente sconosciuto - Info sul continente non disponibili 3
SA - Sud America 2
OC - Oceania 1
Totale 12.452
Nazione #
US - Stati Uniti d'America 6.950
RU - Federazione Russa 1.591
PL - Polonia 790
SE - Svezia 562
IE - Irlanda 539
IT - Italia 325
SG - Singapore 284
HK - Hong Kong 255
UA - Ucraina 226
CN - Cina 197
DE - Germania 172
FI - Finlandia 127
GB - Regno Unito 80
CH - Svizzera 71
IN - India 69
TR - Turchia 55
JO - Giordania 35
CI - Costa d'Avorio 27
BE - Belgio 16
CA - Canada 15
FR - Francia 12
VN - Vietnam 12
KR - Corea 7
NL - Olanda 7
BG - Bulgaria 5
ES - Italia 4
SC - Seychelles 4
AL - Albania 3
EU - Europa 3
MX - Messico 2
AT - Austria 1
CL - Cile 1
IR - Iran 1
JP - Giappone 1
LU - Lussemburgo 1
NZ - Nuova Zelanda 1
UY - Uruguay 1
Totale 12.452
Città #
Santa Clara 1.005
Fairfield 859
Warsaw 790
Chandler 592
Dublin 538
Woodbridge 431
Ashburn 402
Cambridge 374
Seattle 371
Jacksonville 361
Wilmington 305
Houston 302
Singapore 227
Ann Arbor 164
Hong Kong 141
Princeton 133
Lawrence 113
Boston 105
Altamura 100
Boardman 96
Buffalo 89
Beijing 88
Bern 70
Florence 59
Mumbai 59
San Diego 54
Medford 50
Izmir 43
Shanghai 37
Moscow 30
Abidjan 27
Dearborn 27
Norwalk 26
Bremen 23
Los Angeles 22
Kent 21
New York 20
Frankfurt Am Main 14
Hillsboro 13
Andover 12
Auburn Hills 12
Falls Church 12
Milan 11
Brussels 10
Dong Ket 10
Toronto 10
Washington 10
Nanjing 9
Redmond 8
Yubileyny 8
Verona 7
Antwerp 6
Grosseto 6
Guangzhou 6
Salerno 6
Hefei 5
Kunming 5
Munich 5
Philadelphia 5
Barcelona 4
Las Vegas 4
Laurel 4
London 4
Phoenix 4
Saint Petersburg 4
Taranto 4
Brescia 3
Catania 3
Fuzhou 3
Redwood City 3
Riardo 3
San Mateo 3
Sofia 3
Ahmedabad 2
Bari 2
Bologna 2
Cedar Knolls 2
Helsinki 2
Lappeenranta 2
Mantova 2
New Delhi 2
Pune 2
Reynosa 2
Rome 2
Seoul 2
Sesto Fiorentino 2
Shaoxing 2
West Jordan 2
Acton 1
Agliana 1
Ardabil 1
Arezzo 1
Arnsberg 1
Ashford 1
Bottanuco 1
Chaoyang 1
Chengdu 1
Chicago 1
Chiswick 1
Clifton 1
Totale 8.435
Nome #
Antifibrogenic effects of canrenone, an antialdosteronic drug, on human hepatic stellate cells 268
Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis 264
Aggressive gastric carcinoma producing alpha-fetoprotein: a case report and review of the literature. 251
Nitrovasodilators inhibit platelet-derived growth factor-induced proliferation and migration of activated human hepatic stellate cells. 249
Role of endothelin-1 in the migration of human olfactory gonadotropin-releasing hormone-secreting neuroblasts. 243
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial 188
Expression and function of gonadotropin-releasing hormone (GnRH) receptor in human olfactory GnRH-secreting neurons: an autocrine GnRH loop underlies neuronal migration. 152
Plasma levels of brain natriuretic peptide in patients with cirrhosis. 136
Thrombopoietin stimulates migration and activates multiple signaling pathways in hepatoblastoma cells. 132
Reliability of transient elastography for the diagnosis of advanced fibrosis in chronic hepatitis C 131
Autoimmune hepatitis in a patient affected by neuromyelitis optica: A new association. 131
4-Hydroxynonenal as a selective pro-fibrogenic stimulus for activated human hepatic stellate cells. 128
Effect of antiviral treatment in patients with chronic HCV infection and t(14;18) translocation 127
Activation of p38(MAPK) mediates the angiostatic effect of the chemokine receptor CXCR3-B. 125
"Inapparent" hepatitis B virus infection and hepatitis C virus replication in alcoholic subjects with and without liver disease 125
Recent Advancements in Diagnosis and Therapy of Liver Cirrhosis. 125
ADMA correlates with portal pressure in patients with compensated cirrhosis. 123
Albumin improves the response to diuretics in patients with cirrhosis and ascites: results of a randomized, controlled trial. 123
Long-term albumin infusion improves survival in patients with cirrhosis and ascites: an unblinded randomized trial. 123
Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: a randomized trial. 122
DRESS syndrome in a patient with chronic hepatic encephalopathy. 122
Expression and function of integrin receptors for collagen and laminin in cultured human hepatic stellate cells. 119
EFFECTS OF NITRIC OXIDE (NO)-DONORS ON ACTIVATED HUMAN HEPATIC STELLATE CELLS (HSC): CELLULAR BASIS FOR THE TREATMENT OF PORTAL HYPERTENSION. 115
Elevated plasma levels of urotensin II do not correlate with systemic haemodynamics in patients with cirrhosis. 115
THROMBOPOIETIN STIMULATES MIGRATION AND INVASION OF HepG2 CELLS. 114
Cross-talk between phosphatidylinositol 3-kinase (PI3-K) and the NA+/H+ exchanger in hepatic stellate cells (HSC): effect of canrenone. 113
COMBINED PRESENCE OF HCVRNA SEQUENCES AND T(14;18) (q32;q21) TRANSLOCATION IN PBMC FROM PATIENTS WITH CHRONIC HCV INFECTION. 113
CARDIOVASCULAR EFFECTS OF CANRENONE IN PRE-ASCITIC CIRRHOSIS. 112
Interferon and thymosin combination therapy in naive patients with chronic hepatitis C. Preliminary results 111
The src and signal transducers and activators of transcription pathways as specific targets for low molecular weight phosphotyrosine-protein phosphatase in platelet-derived growth factor signaling 111
Performance of Doppler ultrasound in the prediction of severe portal hypertension in hepatitis C virus-related chronic liver disease 111
COMPARISON BETWEEN HEPATIC VENOUS PRESSURE GRADIENT (HVPG) AND LIVER STIFFNESS MEASUREMENT (LSM) IN PATIENTS WITH HCV-RELATED FIBROSIS/CIRRHOSIS 111
CD81 modulation by immobilized monoclonal antibodies is able to promote B-cell proliferation and c-myc expression 110
Screening of distress among hospitalized patients in a department of internal medicine. 109
Cardiovascular effects of canrenone in patients with preascitic cirrhosis 109
Effects of low-dose captopril on renal hemodynamics and function in patients with cirrhosis of the liver. 109
Torasemide in the treatment of patients with cirrhosis and ascites. 108
Expression of IP-10 and its receptor CXCR3 in hepatic stellate cells identifies a novel autocrine and paracrine system. 108
ALBUMIN IMPROVES RESPONSE TO DIURETICS IN DECOMPENSATED CIRRHOTIC PATIENTS. 108
Monocyte chemotactic protein-1 as a chemoattractant for human hepatic stellate cells. 108
Altered clot formation and lysis are associated with increased fibrinolytic activity in ascites in patients with advanced cirrhosis 107
D-dimer and fibrinolytic activity in patients with liver cirrhosis and ascites. Preliminary results. 107
Albumin improves the response to diuretics in patients with cirrhosis and ascites: results of a randomized, controlled trial 106
CD81 MODULATION BY IMMOBILIZED MONOCLONAL ANTIBODIES IS ABLE TO PROMOTE B-CELL PROLIFERATION AND C-MYC EXPRESSION 104
Progression of fibrosis in chronic liver diseases: time to tally the score. 104
Cardiovascular and renal function in normotensive and hypertensive patients with compensated cirrhosis: effects of posture. 104
Ascites and hepatorenal syndrome during cirrhosis: two entities or the continuation of the same complication? 103
The cellular and molecular basis of liver fibrogenesis. 102
Cardiovascular and renal function in normotensive and hypertensive patients with compensated cirrhosis: effects of posture. 102
Combined presence of HCVRNA sequences and t(14;18) (q32;q21) translocation in PBMC from patients with chronic HCV infection 102
CD81 Modulation by Immobilized Monoclonal Antibodies is Able to Promote B-cell proliferation and C-MYC expression 102
Up-regulated expression of fractalkine and its receptor CX3CR1 during liver injury in humans 101
Tyrosine phosphorylation of focal adhesion kinase by PDGF is dependent on Ras in human hepatic stellate cells. 100
Uveitis in autoimmune hepatitis: a case report. 100
The Ras antagonist, farnesylthiosalicylic acid (FTS), inhibits experimentally-induced liver cirrhosis in rats 100
Integrin-mediated stimulation of monocyte chemotactic protein-1 expression. 99
Progression of fibrosis in chronic liver diseases: time to tally the score 99
Hepato-systemic gradient of carbon monoxide in cirrhosis. 99
Focal adhesion kinase and phospholipase C gamma involvement in adhesion and migration of human hepatic stellate cells. 98
Increased plasma carbon monoxide in patients with viral cirrhosis and hyperdynamic circulation. 98
Activation of focal adhesion kinase by PDGF is dependent on Ras in human hepatic stellate cells 96
Pathogenesis and treatment of ascites in hepatic cirrhosis. 96
Pathogenesis and treatment of ascites in hepatic cirrhosis. 95
Ascites and hepatorenal syndrome during cirrhosis: two entities or the continuation of the same complication? 94
QT adaptation during exercise in cirrhosis 93
Regression of T(14;18) bearing B-cell clones following antiviral therapy in chronic HCV infection. 92
Regression of t(14;18) bearing B-cell clones following antiviral therapy in chronic HCV infection 91
Antidepressants and the Risk of Cardiovascular Events in Elderly Affected by Cardiovascular Disease: A Real-Life Investigation from Italy 91
Cardiac and renal response to posture in cirrhotics with and without essential hypertension 91
Characterization of lymphocyte subsets in ascitic fluid and peripheral blood of decompensated cirrhotic patients with chronic hepatitis C and alcoholic liver disease: A pivotal study 88
Hepatorenal syndrome and its treatment today. 88
Is the use of albumin of value in the treatment of ascites in cirrhosis? The case in favour. 87
Regression of t(14;18) bearing B-cell clones following antiviral therapy in chronic HCV infection. 87
EVIDENCE FOR A PATHOGENETIC ROLE OF ASYMMETRIC DIMETHYLARGININE (ADMA) IN CIRRHOTIC PORTAL HYPERTENSION. 87
Increased expression of monocyte chemotactic protein-1 during active hepatic fibrogenesis: correlation with monocyte infiltration. 86
Liver failure complicating segmental hepatic ischaemia induced by a PTFE-coated TIPS stent. 86
Is the use of albumin of value in the treatment of ascites in cirrhosis? The case in favour 85
Diagnosis, treatment and survival of patients with hepatorenal syndrome: A survey on daily medical practice 85
Signal transduction by the chemokine receptor CXCR3 - Activation of Ras/ERK, Src, and phosphatidylinositol 3-kinase/Akt controls cell migration and proliferation in human vascular pericytes 85
IGF-I IS A SURVIVAL FACTOR FOR HUMAN HEPATIC STELLATE CELLS (HSC): INVOLVEMENT OF PI 3-K AND C-AKT 85
CXCR3-binding chemokines as survival factors in human hepatic stellate cells. 84
Extracellular signal-regulated kinase activation differentially regulates platelet-derived growth factor's actions in hepatic stellate cells, and is induced by in vivo liver injury in the rat. 83
Hepatocellular carcinoma and viral cirrhosis. 81
Update on ascites and hepatorenal syndrome 81
LIVER STIFFNESS MEASUREMENT (LSM) IS ABLE TO PREDICT SEVERE PORTAL HYPERTENSION IN PATIENTS WITH HCV-RELATED ADVANCED CHRONIC LIVER DISEASE 80
Renal impairement in chronic liver diseases with and without cholestasis 80
Bcl-2 rearranged B cell clones in chronic HCV infection: a possible factor negatively influencing the virological response to treatment 80
ULTRASTRUCTURAL FEATURES AND DISTRIBUTION OF DENDRITIC CELLS (DC) IN PORTAL INFILTRATES OF PATIENTS WITH HCV-RELATED CHRONIC ACTIVE HEPATITIS (CAH) 78
Expression of platelet-derived growth factor and its receptors in normal human liver and during active hepatic fibrogenesis 75
Uveitis as a presenting feature of autoimmune hepatitis. 74
Estimate of prevalence of glucose intolerance in chronic liver disease. Degree of agreement among some diagnostic criteria. 74
Paradoxical embolization in TIPS: take a closer look to the heart. 74
Cross reactivity due to positive canrenone interference 73
[Viral liver cirrhosis: natural course, pathogenesis and clinical implications of the complications] 72
Efficacia del trattamento antivirale nell’indurre la regressione di cloni B cellulari alberganti la traslocazione t(14;18) nell’infezione cronica da virus C dell’epatite (HCV). 72
Regression of T(14;18) bearing B-cell clones following antiviral therapy in chronic HCV infection. 72
MONOCYTE CHEMOTACTIC PROTEIN-1 STIMULATES HEPATIC STELLATE CELL CHEMOTAXIS. 70
Effect of pentoxifylline on the degradation of procollagen type I produced by human hepatic stellate cells in response to transforming growth factor-beta 1. 69
Organization of the lymphoid tissue in livers with chronic active hepatitis. 69
EFFECTS OF RECOMBINANT HUMAN GAMMA-INTERFERON ON ADVANCED HEPATOCELLULAR CARCINOMA 69
Totale 10.837
Categoria #
all - tutte 33.655
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.655


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.509 0 0 0 0 210 241 258 258 198 139 158 47
2020/20211.188 121 77 101 127 28 180 30 104 98 150 80 92
2021/2022860 24 91 42 39 30 27 29 49 46 25 190 268
2022/20232.374 223 355 109 182 208 422 324 142 247 18 60 84
2023/2024731 22 97 142 48 49 103 26 161 9 19 30 25
2024/20253.321 161 602 381 902 1.275 0 0 0 0 0 0 0
Totale 12.485